» Articles » PMID: 24030419

Thymosin β4 Increases the Potency of Transplanted Mesenchymal Stem Cells for Myocardial Repair

Overview
Journal Circulation
Date 2013 Sep 14
PMID 24030419
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Thymosin β4 (Tβ4) has been shown to enhance the survival of cultured cardiomyocytes. Here, we investigated whether the cytoprotective effects of Tβ4 can increase the effectiveness of transplanted swine mesenchymal stem cells (sMSCs) for cardiac repair in a rat model of myocardial infarction (MI).

Methods And Results: Under hypoxic conditions, cellular damage (lactate dehydrogenase leakage), apoptosis (terminal deoxynucleotidyl transferase dUTP nick end labelingc cells), and caspase-8 activity were significantly lower, whereas B-cell lymphoma-extra large protein expression was significantly higher, in sMSCs cultured with Tβ4 (1 μg/mL) than in sMSCs cultured without Tβ4, and Tβ4 also increased sMSC proliferation. For in vivo experiments, animals were treated with basal medium (MI: n=6), a fibrin patch (Patch: n=6), a patch containing sMSCs (sMSC: n=9), or a patch containing sMSCs and Tβ4 (sMSC/Tβ4: n=11); Tβ4 was encapsulated in gelatin microspheres to extend Tβ4 delivery. Four weeks after treatment, echocardiographic assessments of left-ventricular ejection fraction and fractional shortening were significantly better (P<0.05) in sMSC/Tβ4 animals (left-ventricular ejection fraction=51.7 ± 1.1%; fractional shortening=26.7 ± 0.7%) than in animals from MI (39 ± 3%; 19.5 ± 1.7%) and Patch (43 ± 1.4%; 21.6 ± 0.9%) groups. Histological assessment of infarct wall thickness was significantly higher (P<0.05) in sMSC/Tβ4 animals (50%, [45%, 80%]) than in animals from MI (25%, [20%, 25%]) group. Measurements in sMSC (left-ventricular ejection fraction=45 ± 2.6%; fractional shortening=22.9 ± 1.6%; TH = 43% [25%, 45%]), Patch, and MI animals were similar. Tβ4 administration also significantly increased vascular growth, the retention/survival of the transplanted sMSCs, and the recruitment of endogenous c-Kit(+) progenitor cells to the infarcted region.

Conclusions: Extended-release Tβ4 administration improves the retention, survival, and regenerative potency of transplanted sMSCs after myocardial injury.

Citing Articles

In Vitro Study of Thymosin Beta 4 Promoting Transplanted Fat Survival by Regulating Adipose-Derived Stem Cells.

Li W, Yang Y, Lin Y, Mu D Aesthetic Plast Surg. 2024; 48(11):2179-2189.

PMID: 38409346 DOI: 10.1007/s00266-024-03861-1.


Trends and Challenges in the Development of 3D-Printed Heart Valves and Other Cardiac Implants: A Review of Current Advances.

Bhandari S, Yadav V, Ishaq A, Sanipini S, Ekhator C, Khleif R Cureus. 2023; 15(8):e43204.

PMID: 37565179 PMC: 10411854. DOI: 10.7759/cureus.43204.


Ascorbic acid induces MLC2v protein expression and promotes ventricular-like cardiomyocyte subtype in human induced pluripotent stem cells derived cardiomyocytes.

Gao Y, Su L, Wei Y, Tan S, Hu Z, Tao Z Theranostics. 2023; 13(11):3872-3896.

PMID: 37441603 PMC: 10334833. DOI: 10.7150/thno.80801.


Loss of Histone Methyltransferase KMT2D Attenuates Angiogenesis in the Ischemic Heart by Inhibiting the Transcriptional Activation of VEGF-A.

Meng X, Liu S, Deng T, Li D, You L, Hong H J Cardiovasc Transl Res. 2023; 16(5):1032-1049.

PMID: 36947365 PMC: 10616223. DOI: 10.1007/s12265-023-10373-x.


Recombinant DTβ4-inspired porous 3D vascular graft enhanced antithrombogenicity and recruited circulating CD93/CD34 cells for endothelialization.

Xiao W, Chen W, Wang Y, Zhang C, Zhang X, Zhang S Sci Adv. 2022; 8(28):eabn1958.

PMID: 35857526 PMC: 9278867. DOI: 10.1126/sciadv.abn1958.


References
1.
Toma C, Pittenger M, Cahill K, Byrne B, Kessler P . Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105(1):93-8. DOI: 10.1161/hc0102.101442. View

2.
Hofmann M, Wollert K, Meyer G, Menke A, Arseniev L, Hertenstein B . Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111(17):2198-202. DOI: 10.1161/01.CIR.0000163546.27639.AA. View

3.
Ye L, Haider H, Rusan Tan , Toh W, Law P, Tan W . Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation. 2007; 116(11 Suppl):I113-20. DOI: 10.1161/CIRCULATIONAHA.106.680124. View

4.
Rossdeutsch A, Smart N, Dube K, Turner M, Riley P . Essential role for thymosin β4 in regulating vascular smooth muscle cell development and vessel wall stability. Circ Res. 2012; 111(4):e89-102. DOI: 10.1161/CIRCRESAHA.111.259846. View

5.
Philp D, Scheremeta B, Sibliss K, Zhou M, Fine E, Nguyen M . Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol. 2006; 208(1):195-200. DOI: 10.1002/jcp.20650. View